Netherlands (Kingdom of the) vs Rwanda: Proportion of the target population who received the final dose of
Netherlands (Kingdom of the)
63.0%
in 2024
Rwanda
69.0%
in 2024
Netherlands (Kingdom of the) rank
51st
Rwanda rank
46th
Proportion of the target population who received the final dose of over time
- Netherlands (Kingdom of the)
- Rwanda
How they compare
Rwanda currently reports 69.0% against 63.0% in Netherlands (Kingdom of the), a difference of 6.0%.
That makes Rwanda's figure about 1.1 times Netherlands (Kingdom of the)'s.
The two have swapped places 3 times across 14 shared years of data; in 2011 it was Netherlands (Kingdom of the) ahead.
Netherlands (Kingdom of the) ranks 51st and Rwanda ranks 46th of 107 countries.
Across the 2 decades both report, Netherlands (Kingdom of the) averaged higher in 1 and Rwanda in 1.
Head to head by decade
| Decade | Netherlands (Kingdom of the) | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 54.7% | 65.7% | 11.0% | Rwanda |
| 2020s | 63.2% | 56.8% | 6.4% | Netherlands (Kingdom of the) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Netherlands (Kingdom of the) or Rwanda?
- Rwanda, at 69.0% against 63.0% in Netherlands (Kingdom of the) as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Netherlands (Kingdom of the) and Rwanda?
- 6.0%, with Rwanda ahead.
- How many years of comparable data are there for Netherlands (Kingdom of the) and Rwanda?
- 14 years are reported by both, from 2011 to 2024.
- How do Netherlands (Kingdom of the) and Rwanda rank globally for proportion of the target population who received the final dose of?
- Netherlands (Kingdom of the) ranks 51st and Rwanda ranks 46th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.